Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Moderna, Inc.MRNA · Entity 2025 | Chief Accounting Officer | March 09, 2020 | March 11, 2020 |
| STANDARD BIOTOOLS INC.FLDM · Entity 6116 | See Remarks | February 20, 2018 | February 22, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Moderna, Inc.
Report date March 09, 2020 · Filed March 11, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,419 |
Reported balance
After 2020-03-09 transaction · row 1
1 source rowRow 1 · 2020-03-09 · Sale · Disposed 361 · Balance 4,419 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
STANDARD BIOTOOLS INC.
Report date February 20, 2018 · Filed February 22, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,307 |
Reported balance
After 2018-02-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-02-20 · Exercise / conversion · Acquired 630 · Balance 6,307 F1: Includes 1,153 shares purchased on November 30, 2017 under the Company's 2017 Employee Stock Purchase Plan. |
| Common StockSEC Table I · non-derivative | Direct | 7,432 |
Reported balance
After 2018-02-20 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2018-02-20 · Exercise / conversion · Acquired 1,125 · Balance 7,432 |
| Common StockSEC Table I · non-derivative | Direct | 6,716 |
Reported balance
After 2018-02-20 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2018-02-20 · Tax withholding · Disposed 716 · Balance 6,716 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 5,670 |
Reported balance
After 2018-02-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-02-20 · Exercise / conversion · Disposed 630 · Balance 5,670 F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3: On May 18, 2016, the Reporting Person was granted 10,080 Restricted Stock Units of which 12/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,126 |
Reported balance
After 2018-02-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-02-20 · Exercise / conversion · Disposed 1,125 · Balance 13,126 F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F4: On February 13, 2017, the Reporting Person was granted 18,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 1,153 shares purchased on November 30, 2017 under the Company's 2017 Employee Stock Purchase Plan.
F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
F3: On May 18, 2016, the Reporting Person was granted 10,080 Restricted Stock Units of which 12/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date.
F4: On February 13, 2017, the Reporting Person was granted 18,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2020 Filed Mar 11, 2020 21:37 UTC | Moderna, Inc. MRNA · Entity 2025 | SaleCommon Stock | 361 | $27.33 | $9,865.62 |
DisclosureSEC source: 0001127602-20-010280 · form4.xml · nonDerivative · entry 1 LEE JENNIFER LING · CIK 0001675118 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,419 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:50 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantRestricted Stock Units · Derivative | 8,677 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009068 · form4.xml · derivative · entry 2 LEE JENNIFER LING · CIK 0001675118 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,677 Underlying: Common Stock · 8,677 shares Expires not disclosed F2 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award will vest on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F2 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award will vest on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:50 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantStock Option (Right to Buy) · Derivative | 16,112 | $0.00 Strike: $25.93 | $0.00 |
DisclosureSEC source: 0001127602-20-009068 · form4.xml · derivative · entry 1 LEE JENNIFER LING · CIK 0001675118 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,112 Underlying: Common Stock · 16,112 shares Expires 2030-02-28 F1 · derivative.exercise_date: 25% of this option will vest and become exercisable on February 28, 2021 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 21:16 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantStock Option (Right to Buy) · Derivative | 25,097 | $0.00 Strike: $20.93 | $0.00 |
DisclosureSEC source: 0001127602-19-010841 · form4.xml · derivative · entry 2 LEE JENNIFER LING · CIK 0001675118 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,097 Underlying: Common Stock · 25,097 shares Expires 2029-03-08 F2 · derivative.exercise_date: 25% of this option will vest and become exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 21:16 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantCommon Stock | 4,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-010841 · form4.xml · nonDerivative · entry 1 LEE JENNIFER LING · CIK 0001675118 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,780 F1 · shares: 25% of the shares subject to this restricted stock unit award will vest on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000027 · wf-form4_151933518326452.xml · derivative · entry 5 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,126 Underlying: Common Stock · 1,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F4 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 18,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F4 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 18,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000027 · wf-form4_151933518326452.xml · derivative · entry 4 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,670 Underlying: Common Stock · 630 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: On May 18, 2016, the Reporting Person was granted 10,080 Restricted Stock Units of which 12/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F3 · derivative.expiration_date: On May 18, 2016, the Reporting Person was granted 10,080 Restricted Stock Units of which 12/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 716 | $7.81 | $5,591.96 |
DisclosureSEC source: 0001162194-18-000027 · wf-form4_151933518326452.xml · nonDerivative · entry 3 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,716 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000027 · wf-form4_151933518326452.xml · nonDerivative · entry 2 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,432 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000027 · wf-form4_151933518326452.xml · nonDerivative · entry 1 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,153 shares purchased on November 30, 2017 under the Company's 2017 Employee Stock Purchase Plan. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:02 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000171 · wf-form4_151140251564001.xml · derivative · entry 5 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,251 Underlying: Common Stock · 1,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 18,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F3 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 18,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:02 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000171 · wf-form4_151140251564001.xml · derivative · entry 4 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,300 Underlying: Common Stock · 630 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: On May 18, 2016, the Reporting Person was granted 10,080 Restricted Stock Units of which 12/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F2 · derivative.expiration_date: On May 18, 2016, the Reporting Person was granted 10,080 Restricted Stock Units of which 12/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:02 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 660 | $5.19 | $3,425.40 |
DisclosureSEC source: 0001162194-17-000171 · wf-form4_151140251564001.xml · nonDerivative · entry 3 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,524 Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:02 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000171 · wf-form4_151140251564001.xml · nonDerivative · entry 2 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:02 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000171 · wf-form4_151140251564001.xml · nonDerivative · entry 1 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:15 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 7,053 | Not disclosed Strike: $5.13 | Not disclosed |
DisclosureSEC source: 0001162194-17-000142 · wf-form4_150612933538308.xml · derivative · entry 2 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,053 Underlying: Common Stock · 7,053 shares Expires 2027-09-20 F2 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 13,400 shares of FLDM common stock granted to the Reporting Person on May 18, 2016. In exchange, the Reporting Person received a replacement Option, for 7,053 shares, having an exercise price of $5.13 per share. F3 · derivative.exercise_date: 1/12th of the total number of shares subject to the Option will vest on February 20, 2018, and 1/12th of the total number of shares subject to the Option will vest every three months thereafter until fully vested, subject to the Reporting Person's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:15 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 13,400 | Not disclosed Strike: $8.98 | Not disclosed |
DisclosureSEC source: 0001162194-17-000142 · wf-form4_150612933538308.xml · derivative · entry 1 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,400 shares Expires 2026-05-18 F2 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 13,400 shares of FLDM common stock granted to the Reporting Person on May 18, 2016. In exchange, the Reporting Person received a replacement Option, for 7,053 shares, having an exercise price of $5.13 per share. F1 · derivative.exercise_date: The Option provided for vesting of 12/48th of the total number of shares subject to the Option on May 20, 2017 and thirty-six equal monthly installments beginning on June 20, 2017. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 21:06 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000122 · wf-form4_150352240450010.xml · derivative · entry 5 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,376 Underlying: Common Stock · 1,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 18,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F3 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 18,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 21:06 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000122 · wf-form4_150352240450010.xml · derivative · entry 4 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,930 Underlying: Common Stock · 630 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: On May 18, 2016, the Reporting Person was granted 10,080 Restricted Stock Units of which 12/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to the recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F2 · derivative.expiration_date: On May 18, 2016, the Reporting Person was granted 10,080 Restricted Stock Units of which 12/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to the recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 21:06 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 660 | $3.76 | $2,481.60 |
DisclosureSEC source: 0001162194-17-000122 · wf-form4_150352240450010.xml · nonDerivative · entry 3 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,429 Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 21:06 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000122 · wf-form4_150352240450010.xml · nonDerivative · entry 2 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 21:06 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000122 · wf-form4_150352240450010.xml · nonDerivative · entry 1 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2017 Filed May 23, 2017 22:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 1,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000056 · wf-form4_149558020552485.xml · derivative · entry 5 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,501 Underlying: Common Stock · 1,499 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 18,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F3 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 18,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| May 22, 2017 Filed May 23, 2017 22:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000056 · wf-form4_149558020552485.xml · derivative · entry 4 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,560 Underlying: Common Stock · 2,520 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: On May 18, 2016, the Reporting Person was granted 10,080 Restricted Stock Units of which 12/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F2 · derivative.expiration_date: On May 18, 2016, the Reporting Person was granted 10,080 Restricted Stock Units of which 12/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| May 22, 2017 Filed May 23, 2017 22:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 1,685 | $5.46 | $9,200.10 |
DisclosureSEC source: 0001162194-17-000056 · wf-form4_149558020552485.xml · nonDerivative · entry 3 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,334 Read SEC document |
| May 22, 2017 Filed May 23, 2017 22:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 1,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000056 · wf-form4_149558020552485.xml · nonDerivative · entry 2 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2017 Filed May 23, 2017 22:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 2,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000056 · wf-form4_149558020552485.xml · nonDerivative · entry 1 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:17 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 45,400 | $0.00 Strike: $6.16 | $0.00 |
DisclosureSEC source: 0001162194-17-000014 · wf-form4_148719701479435.xml · derivative · entry 2 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,400 Underlying: Common Stock · 45,400 shares Expires 2027-02-13 F3 · derivative.exercise_date: 1/48th of the total number of shares subject to the option will vest each month after the Vesting Commencement Date, on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that the option will be fully vested on January 1, 2021, subject to recipient continuing to be a Service Provider (as defined in the Fluidigm Corporation 2011 Equity Incentive Plan) through each such date. "Vesting Commencement Date" shall mean January 1, 2017. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:17 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000014 · wf-form4_148719701479435.xml · derivative · entry 1 LEE JENNIFER LING · CIK 0001675118 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: 4/48th of the total number of shares underlying the Restricted Stock Units granted will vest on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F2 · derivative.expiration_date: 4/48th of the total number of shares underlying the Restricted Stock Units granted will vest on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.